Abbott Freestyle Libre
Lingo tracks glucose in real time and delivers personal insights and coaching.
This version of the Health2Sync app is currently available in Japan.
The new device is smaller than previous versions.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.
The study found that the flash continuous glucose monitoring system can cost about 60% less than traditional methods.
Both CGM competitors announced integrations with Insulet yesterday during the Advanced Technologies & Treatment for Diabetes Congress in Madrid.
Bigfoot has agreed to develop and commercialize new programs that will integrate with Abbott's diabetes management platform.
FreeStyle Libre's glucose readings, trends and patterns will all be incorporated into Omada's app.
Sanofi's deal with Abbott will be focusing on the diabetes space, while its deal with Happify will be looking at treating MS symptoms using a digital therapeutic.
The company's executives lauded the CGM system, which saw a 72.9% increase in organic sales during the last quarter, and hinted at implementations of the tech beyond diabetes alone.